CoChat

Use of insulin glargine during pregnancy

Open access
PÖYHÖNEN‐ALHO, MARITTA, RÖNNEMAA, TAPANI, SALTEVO, JUHA, EKBLAD, ULLA, KAAJA, RISTO J. · 2007 · Acta Obstetricia et Gynecologica Scandinavica

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Background. Good metabolic control maintained throughout pregnancy reduces maternal and fetal complications in diabetic women. The long‐acting insulin analogue glargine has 24‐h persistence and a peakless action profile, and could contribute to more stable daily plasma glucose levels and improved glycemic control. We evaluated the metabolic control associated with insulin glargine during pregnancy in comparison with conventional basal insulin therapy. Methods. Retrospective case‐control analysis of glycemic control and pregnancy complications in 100 type 1 diabetic pregnancies with intermediate‐acting NPH insulin or insulin glargine prior to conception and throughout pregnancy. Results. Overall, glycemic control was not different between the groups, though the decrease in HbA1c from the first to the third trimester was greater with insulin glargine (0.8 versus 0.3%, p = 0.04). The rate of hypoglycemia was comparable. Conclusions. Our findings suggest that, as regards metabolic control, insulin glargine in women with type 1 diabetes is comparable with NPH insulin as basal insulin therapy. No adverse effects were associated with glargine use at the time of conception and during pregnancy.

Overview

Integrity signals

Registry

Crossref · 10.1080/00016340701515282

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 18 references

Cited by

See all 57

Metadata

Authors
PÖYHÖNEN‐ALHO, M., RÖNNEMAA, T., SALTEVO, J., EKBLAD, U., & KAAJA, R. J.
Affiliations
  • Helsinki University Hospital (FI)
  • Turku University Hospital (FI)
  • Central Finland Health Care District (FI)
Corresponding author
PÖYHÖNEN‐ALHO, MARITTA
Venue
Acta Obstetricia et Gynecologica Scandinavica
Publisher
Wiley
Published
2007-10
Volume
86
Issue
10
Pages
1171-1174
ISSN
  • 0001-6349 (ISSN-L)
  • 1600-0412
OpenAlex
W2126199017
Cited by
52
References
18
Citations by year
2026: 1 · 2025: 1 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 5 · 2014: 1 · 2013: 5 · 2012: 5
FWCI
4.67
Type
journal article
Language
en
Open access
Locations
  • Acta Obstetricia Et Gynecologica Scandinavica (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
insulin glargine, type 1 diabetes, pregnancy, glycemic control, HbA1c, NPH insulin, basal insulin therapy, hypoglycemia, pregnancy complications, long-acting insulin analogues
MeSH terms
Insulin Glargine, Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Humans, Hypoglycemic Agents, Pregnancy, Pregnancy in Diabetics, Retrospective Studies, Case-Control Studies, Insulin, Long-Acting, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of insulin glargine during pregnancy. https://app.cochat.ai/papers/10.1080/00016340701515282
The paper
PÖYHÖNEN‐ALHO, M., RÖNNEMAA, T., SALTEVO, J., EKBLAD, U., & KAAJA, R. J. (2007). Use of insulin glargine during pregnancy. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1080/00016340701515282

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.